Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDChina SXT Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/31/2025 | Q4 2025 | N/A | -$0.51 | N/A | N/A | $455.71 K |
| 12/31/2024 | Q3 2025 | N/A | -$0.51 | N/A | N/A | $455.71 K |
| 03/28/2025 | Q2 2025 | N/A | -$0.99 | N/A | N/A | $414.75 K |
| 06/30/2024 | Q1 2025 | N/A | -$0.99 | N/A | N/A | $414.75 K |
| 08/13/2024 | Q4 2024 | N/A | $2.67 | N/A | N/A | $494.46 K |
| 12/30/2023 | Q3 2024 | N/A | $2.67 | N/A | N/A | $494.46 K |
| 09/28/2023 | Q2 2024 | N/A | -$9.67 | N/A | N/A | $939.58 K |
| 07/31/2023 | Q1 2024 | N/A | -$9.67 | N/A | N/A | $469.79 K |
| 07/31/2023 | Q4 2023 | N/A | -$5.14 | N/A | N/A | $381.70 K |
| 12/31/2022 | Q3 2023 | N/A | -$5.14 | N/A | N/A | $381.70 K |
| 09/30/2022 | Q2 2023 | N/A | -$7.30 | N/A | N/A | $1.21 M |
| 07/18/2022 | Q1 2023 | N/A | -$7.30 | N/A | N/A | $604.14 K |
| 07/18/2022 | Q4 2022 | N/A | -$25.39 | N/A | N/A | $787.30 K |
| 12/31/2021 | Q3 2022 | N/A | -$25.39 | N/A | N/A | $787.30 K |
| 01/14/2022 | Q2 2022 | N/A | -$49.71 | N/A | N/A | $513.84 K |
| 08/13/2021 | Q1 2022 | N/A | -$49.71 | N/A | N/A | $513.84 K |
| 08/13/2021 | Q4 2021 | N/A | -$71.73 | N/A | N/A | $458.54 K |
| 12/31/2020 | Q3 2021 | N/A | -$71.73 | N/A | N/A | $458.54 K |
| 09/29/2020 | Q2 2021 | N/A | $24.00 | N/A | N/A | $1.93 M |
| 07/31/2020 | Q1 2021 | N/A | $24.00 | N/A | N/A | $1.93 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
China SXT Pharmaceuticals Inc Earnings: FAQ's
The conference call for China SXT Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for China SXT Pharmaceuticals Inc's latest earnings report can be read online.
China SXT Pharmaceuticals Inc (:SXTC) has a recorded annual revenue of $1.74 M.
China SXT Pharmaceuticals Inc (:SXTC) has a recorded net income of $-3,303,652.China SXT Pharmaceuticals Inc has generated $-8.18 earnings per share over the last four quarters.
China SXT Pharmaceuticals Inc (:SXTC) has a price-to-earnings ratio of -1.72 and price/earnings-to-growth ratio is 0.